140 related articles for article (PubMed ID: 21130120)
1. Role of endogenous oxytocin in cardiac ischemic preconditioning.
Alizadeh AM; Faghihi M; Sadeghipour HR; Mohammadghasemi F; Khori V
Regul Pept; 2011 Feb; 167(1):86-90. PubMed ID: 21130120
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
3. Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in the in vivo anesthetized rabbit heart?
Das B; Sarkar C
Life Sci; 2012 May; 90(19-20):763-9. PubMed ID: 22525371
[TBL] [Abstract][Full Text] [Related]
4. Role of atrial natriuretic Peptide in oxytocin induced cardioprotection.
Houshmand F; Faghihi M; Zahediasl S
Heart Lung Circ; 2015 Jan; 24(1):86-93. PubMed ID: 25126708
[TBL] [Abstract][Full Text] [Related]
5. Effects of trimetazidine on myocardial preconditioning in anesthetized rats.
Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
Eur J Pharmacol; 2004 Oct; 503(1-3):135-45. PubMed ID: 15496308
[TBL] [Abstract][Full Text] [Related]
6. The effect of acute stress exposure on ischemia and reperfusion injury in rat heart: role of oxytocin.
Moghimian M; Faghihi M; Karimian SM; Imani A
Stress; 2012 Jul; 15(4):385-92. PubMed ID: 22044052
[TBL] [Abstract][Full Text] [Related]
7. Role of central oxytocin in stress-induced cardioprotection in ischemic-reperfused heart model.
Moghimian M; Faghihi M; Karimian SM; Imani A; Houshmand F; Azizi Y
J Cardiol; 2013 Jan; 61(1):79-86. PubMed ID: 23159205
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
Balakumar P; Rohilla A; Singh G; Singh K; Singh M
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
[TBL] [Abstract][Full Text] [Related]
9. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats.
Houshmand F; Faghihi M; Zahediasl S
Peptides; 2009 Dec; 30(12):2301-8. PubMed ID: 19761809
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effect of sasanquasaponin preconditioning via bradykinin-NO pathway in isolated rat heart.
Liao Z; Yin D; Wang W; Zeng G; Liu D; Chen H; Huang Q; He M
Phytother Res; 2009 Aug; 23(8):1146-53. PubMed ID: 19165801
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion.
Ondrejcakova M; Ravingerova T; Bakos J; Pancza D; Jezova D
Can J Physiol Pharmacol; 2009 Feb; 87(2):137-42. PubMed ID: 19234577
[TBL] [Abstract][Full Text] [Related]
14. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Rohilla A; Singh G; Singh M; Bala kumar P
Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
[TBL] [Abstract][Full Text] [Related]
18. The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.
Rohilla A; Balakumar P
Biomed Pharmacother; 2009 Dec; 63(10):787-91. PubMed ID: 19914793
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.
Deuchar GA; Opie LH; Lecour S
Life Sci; 2007 Apr; 80(18):1686-91. PubMed ID: 17316703
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective and anti-apoptotic effects of Potentilla reptans L. root via Nrf2 pathway in an isolated rat heart ischemia/reperfusion model.
Enayati A; Yassa N; Mazaheri Z; Rajaei M; Pourabouk M; Ghorghanlu S; Basiri S; Khori V
Life Sci; 2018 Dec; 215():216-226. PubMed ID: 30419282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
